openPR Logo
Press release

Adult Vaccines Market: Global Industry Insights Analysis and Forecast to 2025

02-15-2018 12:37 PM CET | Health & Medicine

Press release from: CMI - Pharmaceutical Research

Adult Vaccines Market: Global Industry Insights Analysis

Vaccination is one of the most effective and safest therapies that provides protection against diseases. Most vaccines are recommended on the basis of age, lifestyle, travel destinations, and health conditions such as diabetes, heart diseases, asthma, and chronic obstructive pulmonary disease (COPD). According to Centers for Disease Control and Prevention (CDC), in 2013, around 226,000 people are hospitalized every year and between 3,000 and 49,000 people die due to influenza and its complications, with major being adults. CDC recorded the financial burden of adult vaccine preventable diseases (VPD) in the U.S. to be around US$ 10 billion, annually and recommends adults to be vaccinated against various infections such as influenza, pertussis (whooping cough), chickenpox, diphtheria, measles, hepatitis A and B, meningococcal disease (meningitis), human papillomavirus, mumps, pneumococcal disease (pneumonia), rubella, shingles, and tetanus.

Request a sample copy of this report:

Initiatives by state authorities against viral and bacterial infections and innovation of novel vaccines is expected to fuel growth of the market

In August 2017, GlaxoSmithKline and Ali health promoted HPV/Cervarix – which is a part of online shopping program named Taobao. It offers several pediatric and adult vaccine information and links of 1500 health clinics for consultations and appointments in China. This in turn, is expected to fuel growth of the adult vaccines market in the near future. Moreover, Dallas County Health and Human Services (DCHHS), in August 2017, offered seasonal flu vaccine for adults, which is an all-in-one shot vaccine for multiple flu strains, including H1N1.

According to Public Health England (PHE), reported that nasal influenza vaccine reduced risk of influenza for children, however, not for adults. PHS suggest the development of new vaccines, which may provide better protection from infections among the geriatric population. This in turn, is expected to provide key players operating in adult vaccine market, high opportunity to develop effective vaccines for geriatric population.

Increasing prevalence infections among adults fuels growth of the adult vaccines market

According to the Immunization Action Coalition (IAC), a member of the WHO-led project Vaccine Safety Net (VSN), around 166,000 cases of flu were reported in the U.S. and around 71 people died in September 2017. Moreover, in 2016, around 91,000 people were impacted from flu over the last five years. Moreover, in Canada, Vancouver Coastal Health issued a warning to teens and young adults against mumps in 2017. According to CDC, people traveling every year for business and vacations are at a higher risk of developing infections. The state and local healthcare authorities have made vaccination a compulsion for travelers, which in turn, is expected to fuel growth of the adult vaccines market.

Key players operating in the global adult vaccines market include GlaxoSmithKline plc, Panacea Biotec, Pfizer, Inc., Protein Sciences Corporation, Merck & Co., Inc., Daiichi Sankyo, Sanofi Pasteur SA, Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Bavarian Nordic, CSL Limited, Serum Institute of India Pvt. Ltd., ), Emergent BioSolutions, Inc., MedImmune, LLC, and Johnson & Johnson.

Browse Market Research Report @

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Visit our news Website:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adult Vaccines Market: Global Industry Insights Analysis and Forecast to 2025 here

News-ID: 945013 • Views: 476

More Releases from CMI - Pharmaceutical Research

Global Pulmonary Arterial Hypertension (PAH) Market - Pfizer, Inc., Actelion Pharmaceuticals, Ltd., Gilead Sciences, Inc.
Global Pulmonary Arterial Hypertension (PAH) Market - Pfizer, Inc., Actelion Pha …
Pulmonary hypertension or PH is a condition in which the blood pressure rises in the pulmonary artery, vein, or capillaries (collectively known as lung vasculature), which might lead to shortness of breath, fainting, leg swelling, and dizziness, among others. Pulmonary hypertension may be a relentless disease with a noticeable reduction in exercise tolerance. Pulmonary arterial hypertension or PAH indicates that the patient has high blood pressure in arteries that carry
Betaxolol Market - Size, Share, Growth, Outlook, and Trends Analysis 2018–2026
Betaxolol Market - Size, Share, Growth, Outlook, and Trends Analysis 2018–2026
Betaxolol is a racemic mixture and beta-adrenergic receptor inhibitor used to treat patients with chronic open-angle glaucoma or ocular hypertension. It was first approved by the U.S. Food and Drug Administration (FDA) in 1989, as an oral tablet. Betaxolol is used either alone or in combination with other medicines to lower down the pressure within the heart or eye. In the heart, Betaxolol decreases the cardiac contractility and rate selectively
Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2 …
Cervical cancer develops in women’s cervix, and mainly affects sexually active women aged between 30 and 45. Cervical cancer often shows no symptoms in early stages. However, the death rate of cervical cancer can be significantly reduced with use of Pap test (Papanicolaou test): a screening procedure which can detect the changes in the cervix before the cancer develops. There are different types of cervical cancer, out of which two

All 5 Releases

More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the